Richard J. Wall
London, ENG WC1E7HT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Using Unbiased Chemical Proteomics Approaches to Explore the Target Landscape of the Resistance Refractory 7-Azaindole MMV022224 in Plasmodium falciparum.
Journal: ACS infectious diseases
Published: June 25, 2026
Menaquinone depletion resensitises bedaquiline-resistant tuberculosis.
Journal: bioRxiv : the preprint server for biology
Published: February 23, 2026
Menaquinone depletion resensitises bedaquiline-resistant tuberculosis.
Journal: bioRxiv : the preprint server for biology
Published: February 23, 2026
PurFect timing: revisiting purine metabolism for tuberculosis treatment.
Journal: Trends in microbiology
Published: July 28, 2025
Antitrypanosomal quinazolines targeting lysyl-tRNA synthetase show partial efficacy in a mouse model of acute Chagas disease.
Journal: Science translational medicine
Published: July 09, 2025
Author Correction: An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates.
Journal: Scientific reports
Published: April 04, 2025
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.
Journal: Nature communications
Published: November 04, 2024
ResMAP-a saturation mutagenesis platform enabling parallel profiling of target-specific resistance-conferring mutations in Plasmodium.
Journal: mBio
Published: August 27, 2024
Targeting de novo purine biosynthesis for tuberculosis treatment.
Journal: Nature
Published: August 14, 2024
Post-transcriptional reprogramming by thousands of mRNA untranslated regions in trypanosomes.
Journal: Nature communications
Published: February 21, 2024
Last Updated: 09/26/2026